NL7513370A - Werkwijze voor de bereiding van farmaceutische samenstellingen onder toepassing van l-dopa of verbindingen daarvan. - Google Patents

Werkwijze voor de bereiding van farmaceutische samenstellingen onder toepassing van l-dopa of verbindingen daarvan.

Info

Publication number
NL7513370A
NL7513370A NL7513370A NL7513370A NL7513370A NL 7513370 A NL7513370 A NL 7513370A NL 7513370 A NL7513370 A NL 7513370A NL 7513370 A NL7513370 A NL 7513370A NL 7513370 A NL7513370 A NL 7513370A
Authority
NL
Netherlands
Prior art keywords
dopa
compounds
preparation
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
NL7513370A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NL7513370A publication Critical patent/NL7513370A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7513370A 1974-11-14 1975-11-14 Werkwijze voor de bereiding van farmaceutische samenstellingen onder toepassing van l-dopa of verbindingen daarvan. NL7513370A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49131304A JPS5157813A (en) 1974-11-14 1974-11-14 Ll dooba mataha sonojudotaiseizaino seiho

Publications (1)

Publication Number Publication Date
NL7513370A true NL7513370A (nl) 1976-05-18

Family

ID=15054818

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7513370A NL7513370A (nl) 1974-11-14 1975-11-14 Werkwijze voor de bereiding van farmaceutische samenstellingen onder toepassing van l-dopa of verbindingen daarvan.

Country Status (10)

Country Link
US (1) US3961041A (xx)
JP (1) JPS5157813A (xx)
CA (1) CA1047928A (xx)
DE (1) DE2551280A1 (xx)
ES (1) ES442579A1 (xx)
FR (1) FR2290912A1 (xx)
GB (1) GB1485676A (xx)
IT (1) IT1069069B (xx)
NL (1) NL7513370A (xx)
SE (1) SE7512740L (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147768A (en) * 1976-09-13 1979-04-03 Interx Research Corporation Enteric coated digoxin and therapeutic use thereof
JPS54138128A (en) * 1978-04-19 1979-10-26 Akiyama Jiyouzai Kk Double contrast medium for intestine
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB2130087A (en) * 1982-09-22 1984-05-31 Dr Joachime Helbig Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4663349A (en) * 1985-12-30 1987-05-05 Merck & Co., Inc. Rectally absorbable form of L-dopa
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
DE3779500T2 (de) * 1986-06-10 1993-01-21 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5354885A (en) * 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
US5607969A (en) * 1992-12-24 1997-03-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem L-DOPA ethyl ester to treat Parkinson's disease
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
US7060734B1 (en) 1997-09-09 2006-06-13 Alza Corporation Pharmaceutical coating composition and method of use
ES2232021T3 (es) * 1997-09-09 2005-05-16 Alza Corporation Composicion para recubrimiento farmaceutico y procedimiento de utilizacion.
ATE246506T1 (de) * 1998-03-11 2003-08-15 Grelan Pharmaceutical Co Darmlösliche sprudelnde zusammensetzungen
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6576250B1 (en) 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
EP2127642A3 (en) * 1998-08-13 2010-02-24 Cima Labs, Inc. Microemulsions as solid dosage forms for oral administration
EP1135118A1 (en) 1998-11-10 2001-09-26 Teva Pharmaceutical Industries Ltd. Dispersible compositions containing l-dopa ethyl ester
EP1137626A4 (en) 1998-11-10 2002-07-17 Teva Pharma METHOD FOR PRODUCING L-DOPA ETHYLESTER
KR100299562B1 (ko) 1998-12-29 2001-11-22 우재영 안정성을극대화시킨5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸유도체함유미세과립
AU2005202472B2 (en) * 1999-04-29 2008-12-18 Cima Labs Inc. Effervescent drug delivery system for oral administration
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
EP1708686B1 (en) * 2003-12-31 2011-02-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
JP2016029034A (ja) * 2014-07-18 2016-03-03 ナノメガ メディカル コーポレイションＮａｎｏｍｅｇａ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 医薬組成物
JP2017203031A (ja) * 2017-07-12 2017-11-16 スティッチング グロニンゲン セントル フォー ドラッグ リサーチ ｐＨ制御パルス送達システム、その調製法及び使用法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
FR2116256A1 (en) 1970-12-02 1972-07-13 Sobio Lab Enteric - coated l-dopa - for treatment of parkinsonism with reduced gastrointestinal side-effects
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa

Also Published As

Publication number Publication date
CA1047928A (en) 1979-02-06
FR2290912A1 (fr) 1976-06-11
SE7512740L (sv) 1976-05-17
DE2551280A1 (de) 1976-05-20
FR2290912B1 (xx) 1978-07-28
GB1485676A (en) 1977-09-14
US3961041A (en) 1976-06-01
JPS5436645B2 (xx) 1979-11-10
IT1069069B (it) 1985-03-25
JPS5157813A (en) 1976-05-20
ES442579A1 (es) 1978-01-16

Similar Documents

Publication Publication Date Title
NL7513370A (nl) Werkwijze voor de bereiding van farmaceutische samenstellingen onder toepassing van l-dopa of verbindingen daarvan.
NL7414283A (nl) Werkwijze voor de bereiding van silanen.
NL7510478A (nl) Werkwijze voor de bereiding van multiheteromacro- ringverbindingen.
NL7509159A (nl) Werkwijze voor de bereiding van etherstructuren bevattende dihydroxysulfonaten.
NL153205B (nl) Werkwijze voor de bereiding van organotintrihalogeniden.
NL7507803A (nl) Werkwijze voor de bereiding van stilbeenderivaten.
NL7510226A (nl) Werkwijze voor de bereiding van androstaanderiva- ten.
NL7409832A (nl) Werkwijze voor de bereiding van farmaceu- tische samenstellingen.
NL7511240A (nl) Werkwijze voor de bereiding van octahydroindolo- -chinolizine derivaten.
NL7501124A (nl) Werkwijze voor de bereiding van organofosfinen.
NL7515096A (nl) Werkwijze voor de bereiding van pinakolien.
NL7502846A (nl) Werkwijze voor de bereiding van parasiticiden.
NL7508232A (nl) Werkwijze voor de bereiding van cyclododecatrieen.
NL7509132A (nl) Werkwijze voor de bereiding van cefalosporinen.
NL7504016A (nl) Werkwijze voor de bereiding van isochinolinen.
NL7510753A (nl) Werkwijze voor de bereiding van 6-chloor-2-chloor- methyl-4-fenylchinazoline-3-oxyde.
NL7500686A (nl) Werkwijze voor de bereiding van cyclopentaan- dionen.
NL7511067A (nl) Werkwijze voor de bereiding van orgoteinederi- vaten.
NL7503876A (nl) Werkwijze voor de bereiding van hydrazinocefa- losporineverbindingen.
NL7504718A (nl) Werkwijze voor de bereiding van 5-nitro- imidazoolverbindingen.
NL7505108A (nl) Farmaceutisch preparaat voor de behandeling van kanker.
NL7503746A (nl) Werkwijze voor de bereiding van 2-nitrobenzal- dehyde.
NL7509679A (nl) Werkwijze voor de bereiding van difenylbutylpi- peridinen.
NL7503515A (nl) Werkwijze voor de bereiding van metformine-clo- fibraat.
NL7507976A (nl) Werkwijze voor de bereiding van hydroxyalkylxanthinen.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed